Envoy Medical Inc(COCH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:02 PM ET (Korea 11/4 06:02)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -7.75 | Insider Own | 40.23% | Shs Outstand | 7.7M | Perf Week | 1.69% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 18.12% | Insider Trans | - | Shs Float | 4.6M | Perf Month | 1.69% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.67 | Inst Own | 23.1% | Short Float | 1.25% | Perf Quarter | -3.22% |
| Income | -0.03B | P/S | 243.99 | EPS this Y | 76.67% | Inst Trans | - | Short Ratio | 4.65 | Perf Half Y | -5.02% |
| Sales | 0.00B | P/B | 15.47 | EPS next 5Y | 42.24% | ROA | -138.27% | Short Interest | 0.06M | Perf YTD | 0.14% |
| Book/sh | 0.43 | P/C | 2.6 | EPS past 3/5Y | 7.81% -942.66% | ROE | - | 52W High | -30.6% ($9.54) | Perf Year | -13.32% |
| Cash/sh | 2.54 | P/FCF | - | Sales past 3/5Y | 0.56% - | ROIC | -587.82% | 52W Low | 82.62% ($3.62) | Perf 3Y | -36.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 42.7% | Gross Margin | -385.51% | Volatility(W/M) | 8.13% 8.64% | Perf 5Y | -93.21% |
| Dividend TTM | - | EV/Sales | 154.13 | Sales Y/Y TTM | -6.76% | Oper. Margin | -11411.11% | ATR (14) | 0.54 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.61 | EPS Q/Q | 78.47% | Profit Margin | -13747.34% | RSI (14) | 50.5 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.73 | Sales Q/Q | -34.62% | SMA20 | 2.13% ($6.48) | Beta | 2.01 | Target Price | $21.67 |
| Payout | - | Debt/Eq | 0.25 | Earnings | 2026/11/5 | SMA50 | -3.01% ($6.83) | Rel Volume | 0.9 | Prev Close | $6.65 |
| Employees | 43 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 12.5% 2% | SMA200 | -3.62% ($6.87) | Avg Volume(3M) | 0.01M | Price | $6.62 |
| IPO | 2021/4/29 | Option/Short | No/Yes | Trades | 161 | Volume | 11,163 | Change | -0.45% |
A medical device company that develops innovative cochlear implants and hearing solutions designed to be 100% implanted inside the body without any external devices.
Over the past 1 year, roughly in the middle
31% below its 1-year high.
Traded about as much as usual. That is 90% of its average volume.
Next earnings report: November 5
1 days to go.
COCH has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +76.7% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $24,399. Peers typically go for $145.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -93.2%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 23.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #94 of 140 in the industry
Based on market cap of $51M.
SRTS#93 Sensus Healthcare Inc $54M PER - COCH#94 Envoy Medical Inc $51M PER - 
SNWV#95 Sanuwave Health Inc $51M PER 24.7 
MYO#96 Myomo Inc $51M PER - 
MDAI#97 Spectral AI Inc $48M PER - 
FAQ
What kind of company is COCH?
COCH belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of COCH?
The market cap of COCH is approximately $51M, ranking 4,828 within its sector.
What is the 52-week high and low for COCH?
COCH has recorded a 52-week high of $9.54 and a low of $3.62.
